Comparison of the Effectiveness of Abortive Measures From the Administration of Mifegyne and Cytotec at One and Two Visits

Trial Profile

Comparison of the Effectiveness of Abortive Measures From the Administration of Mifegyne and Cytotec at One and Two Visits

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Mifepristone (Primary) ; Misoprostol (Primary)
  • Indications Induced abortion
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2010 Planned End Date changed from 1 Jan 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 24 Mar 2010 Actual initiation date (Jun 2009), patient number (200) and primary outcome added as reported by ClinicalTrials.gov.
    • 24 Mar 2010 Planned end date (1 Jan 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top